Equity
DOKTER PETER MOONS paid out €307,689 in dividends. That is 130% of the 2025 profit.
DOKTER PETER MOONS paid out €307,689 in dividends. That is 130% of the 2025 profit.
The last five annual accounts were filed 6 to 35 days before the end of the period.
More equity than 93% of companies in human health. Sector median €124,552 · 20,762 companies.
The dashed line is the sector median: < 0.1% across 24,183 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 95% on liquidity, 56% on profitability and 29% on growth.
The bankruptcy probability was computed on 07-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 20,137 companies had the same profile as DOKTER PETER MOONS has now. Each dot stands for 51 companies, two years later.
That fits the bankruptcy probability of DOKTER PETER MOONS itself: < 0.1% within 12 months.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 20,137 companies, not a prediction for DOKTER PETER MOONS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is ample, with a current ratio of 22.15 (46.3 in 2024), above the usual 1.5. Short-term debt is 4% and cash 40.5% of total assets. 6.6% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 7 accounts on average 22 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| DOKTER PETER MOONS Aalter | €1.1m | €414,269 | 93.4% | - |
| DR. DE NEVE - DR. DRIEGHE Aalter | €1.1m | €431,682 | 84.9% | - |
| Dr. S. HUYBRECHTS - Dr. K. CASIER Nazareth-De Pinte | €1.0m | €439,034 | 73.0% | - |
| DR. FRANK PROVENIER CARDIOLOOG Maldegem | €1.1m | €427,960 | 74.0% | - |
| DR. S. SUYKENS - ANESTHESIOLOGIE Oosterzele | €1.0m | €380,510 | 56.0% | - |
| Dr. B. VAN LIEFFERINGE Eeklo | €1.1m | €425,000 | 48.4% | - |
| KEMPENEERS OOGHEELKUNDE Eeklo | €1.2m | €392,509 | 80.0% | - |
These companies have the same main activity as DOKTER PETER MOONS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1m and €1.2m, founded between 1998 and 2003.
DOKTER PETER MOONS files the micro format. That format states no turnover. The gross margin rose from €181,668 in 2006 to €414,269 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.